Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Lung Protective Ventilation With Extracorporeal CO2 Removal During Acute Respiratory Distress Syndrome

NCT03525691 is registered in ClinicalTrials.gov with Hôpital Européen Marseille as lead sponsor.

NCT NCT03525691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03525691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Lung Protective Ventilation With Extracorporeal CO2 Removal During Acute Respiratory Distress Syndrome
Lead sponsor
Hôpital Européen Marseille
Phase
Not applicable
Overall status
Terminated
Start date
May 23, 2018
Completion date
December 5, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, human, ventilator-induced lung injury